Zheng Quan Shi Bao Wang·2025-05-23 10:11Group 1 - The Helicobacter pylori concept sector increased by 1.28%, ranking fifth among concept sectors, with 48 stocks rising, including New World and Haisan Pharmaceutical reaching a 20% limit up [1] - Major gainers in the Helicobacter pylori sector included Zhongsheng Pharmaceutical, *ST Sailong, and others, with increases of 8.80%, 7.82%, and 3.77% respectively [1] - The sector saw a net inflow of 599 million yuan from main funds, with 34 stocks receiving net inflows, and five stocks exceeding 50 million yuan in net inflow [2] Group 2 - The top three stocks by net inflow in the Helicobacter pylori sector were Haisan Pharmaceutical (179 million yuan), Zhongsheng Pharmaceutical (177 million yuan), and Jiaoda Onlly (128 million yuan) [2] - The net inflow ratios for Zhongsheng Pharmaceutical, Jiaoda Onlly, and Haisan Pharmaceutical were 42.93%, 18.92%, and 15.92% respectively [3] - The overall performance of the Helicobacter pylori sector was supported by significant trading volumes, with Haisan Pharmaceutical achieving a turnover rate of 39.86% [3]